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ABSTRACT 
Objective: While vaccination in pregnancy has the potential to dramatically impact maternal and 
infant morbidity and mortality, uptake of recommended vaccinations in pregnancy remains low.  
Our objective was to identify barriers and facilitators of vaccination during pregnancy in Canada.  
Methods: The MEDLINE database, as well as the table of contents of four relevant Canadian 
journals were screened to identify all studies that considered barriers and/or facilitators to 
vaccination during pregnancy, specifically in Canadian settings.  Citations were screened and a 
narrative synthesis of findings was undertaken given the heterogeneity of study design.  
Results: In total, 17 studies met inclusion criteria, most with a focus on the seasonal and 
pandemic influenza vaccines.  Facilitators and barriers were identified at the level of the patient 
and the provider.  At both levels, knowledge was an important facilitator of vaccine acceptance 
during pregnancy and was notably improved in studies following the 2009 pandemic H1N1 
influenza compared to earlier studies.  Vaccine endorsement by a prenatal care provider and 
clear messages of safety for the fetus emerged as key motivators. Few studies addressed system 
level barriers or interventions for improving vaccine uptake during pregnancy in the Canadian 
setting.  
Conclusions: Common themes have emerged from the Canadian literature addressing barriers 
and facilitators of vaccination during pregnancy.  However, there is a paucity of literature to 
suggest strategies to improve the uptake of vaccination during pregnancy in Canadian settings.  
Further research is urgently needed given the expanding role of vaccination during routine 
prenatal care.  
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INTRODUCTION 
Vaccination in pregnancy has the potential to dramatically impact maternal and infant morbidity 
and mortality.  A prime example is the widespread introduction of routine tetanus vaccination 
during pregnancy throughout the developing world, which led to a 93% reduction in maternal 
and neonatal tetanus over the last quarter century1.  More recently, in developed nations the 
influenza and acellular pertussis (Tdap) vaccines have become the focus of maternal vaccination 
initiatives2, and new vaccines in development (e.g. for Respiratory Syncytial Virus, Group B 
Streptococcus) may eventually be recommended in pregnancy.  Currently in Canada, the 
influenza vaccine is recommended for all pregnant individuals. As of March 2018 Tdap is also 
recommended by the National Advisory Committee on Immunization3 for all pregnant 
individuals in every pregnancy. However in Canada, for reasons that remain unclear, uptake of 
these vaccinations has been limited relative to comparator countries,. 
Provincial/territorial estimates for influenza vaccine coverage during pregnancy are not 
calculated for all Canadian jurisdictions, but where available, estimates of the proportion of 
women vaccinated against the influenza during pregnancy remain well below 50%.  In Nova 
Scotia, only 17.5% of pregnant women received the influenza vaccine in 2016, compared to 
64.1% of adults >65 years4. Comparable rates of influenza vaccine uptake were seen among 
pregnant women in Alberta in 2014-2015 with a 14.58% rate of uptake compared to 62.39% 
uptake among seniors and 34.9% uptake for children aged 6-23 months5.  In contrast, population-
based estimates from other developed countries suggest uptake rates of 26% in England6 and as 
high as 40-50% in Australia,7,8 Ireland9 and the United States10.   
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The contrast between rates of influenza vaccine coverage for pregnant women in Canada 
compared to those of pregnant women in similarly-resourced countries is striking, leading to 
questions regarding the barriers and facilitators for vaccination in pregnancy in the Canadian 
context. MacDougall and Halperin11 conducted a scoping review of barriers and facilitators to 
uptake of maternal immunization internationally, finding influences at the patient-level (e.g., 
vaccine knowledge, perceived disease severity, concern over vaccine safety), health care 
provider-level (e.g., age, specialty, practice type, and vaccine attitudes), and systems-level (e.g., 
costs, reimbursement methods, and IT infrastructure).   The current analysis builds on the work 
by MacDougall and Halperin to systematically conduct a more comprehensive review of 
empirical research on vaccination in pregnancy specifically in Canadian settings, with the 
objective of identifying factors that prevent or facilitate vaccination of pregnant individuals in 
Canada.  
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METHODS 
This study systematically reviewed empirical research that identified barriers and facilitators to 
vaccination in pregnancy among Canadian populations.  
Search Strategy 
We sought peer-reviewed studies in French or English that used any empirical research method 
to identify barriers and/or facilitators to vaccination in pregnancy in Canadian settings. Prior to 
2001 publically funded provincial programs for influenza vaccine were rare, and Canadian 
recommendations to include pregnant individuals in influenza vaccination programs have been 
issued in subsequent years; therefore we sought studies published 2001-2017. Studies were 
identified through a combination of electronic database searching, searches of key Canadian 
journals of interest, by hand-searching reference lists of included articles for additional citations, 
and by consulting Canadian immunization experts for assistance identifying any studies the 
previous methods failed to find.  
We searched the MEDLINE database using the Ovid interface on July 11, 2017, by combining 
MeSH terms for vaccines, vaccination, and immunization with pregnancy and with Canada (all 
exploded to include all relevant subheadings; see Appendix for search detail).1 Searches were 
conducted by author VP in consultation with author DG, an MLIS-qualified information scientist 
with expertise in health services and policy reviews. Results were limited to articles focusing on 
humans that were written in English or French and published in 2001 or after. We electronically 
searched the contents of the four Canadian journals most likely to publish peer reviewed studies 
                                                          
1 An additional pilot search of the CINAHL nursing database did not result in unique relevant citations; therefore 
we did not export and assess these results with the others.  
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of vaccination in pregnancy (Journal of Obstetrics & Gynaecology Canada, Canadian Medical 
Association Journal, Canadian Family Physician, and Canadian Journal of Public Health). We 
then identified additional citations by asking experts on the topic for any missing Canadian 
literature, and through hand-searching the reference lists of identified articles on the topic.   
Inclusion and Exclusion Criteria 
Studies eligible for inclusion focused wholly or in part on a Canadian population and on 
vaccination in pregnancy, were peer-reviewed, published in 2001 or later in English or French, 
and identified, attempted to address, or otherwise studied barriers to or facilitators of vaccination 
in pregnancy, using any empirical research method. Studies that did not identify or address 
patient, provider, or system barriers and/or facilitators to vaccination of pregnant individuals in 
Canada were excluded from the study, as were commentaries, review articles without meta-
analysis, clinical guidelines, cost-effectiveness analyses and studies that focused on outcomes of 
vaccination in pregnancy.   
Citation Screening  
Citations identified though our searches were exported to an EndNote database. After de-
duplication, titles and abstracts were screened and articles that did not meet inclusion criteria 
were excluded. All potentially-includable articles were obtained in full text and read to ensure 
that they met inclusion criteria, and any that did not were discarded prior to data extraction and 
analysis.  Two authors assessed all studies for inclusion (VP and DG) and any disagreements 
about eligibility were decided by the third author (EC).  See Figure 1 for PRISMA Flow 
Diagram of the search and screening process.   
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Figure 1. Prisma Diagram of Search and Screening Process 
 
Data Analysis 
Data was abstracted from included studies using Microsoft Excel, within which studies were 
characterized according to their year of publication, population attributes, research method(s), 
vaccine(s) under study, and whether the study addressed barriers and/or facilitators at the patient, 
population or system level.  Given the heterogeneity of study design among the studies, 
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statistical meta-analysis was not possible; therefore we conducted a narrative synthesis of factors 
at each level.  
RESULTS 
A total of 57 studies were identified through the MEDLINE search and 107 were identified by 
searching journal contents. After de-duplication, this totaled 140 unique citations, which were 
winnowed to 15 by screening title and abstract. An additional 6 studies were identified through 
hand-searching the reference lists of published articles and by asking experts on the topic for any 
missing Canadian literature.  Figure 1 depicts the flow of citations through the different stages of 
this review, including reasons for excluding 4 of these 21 full text documents. In total, 17 studies 
met inclusion criteria. These included studies are summarized in Table 1.   
Author, Date Data 
Year 
Vaccine Study 
Methods 
Setting Population Barriers / 
Facilitators 
Limitations 
Bettinger, 2016 2010-
2011 
Seasonal 
influenza 
immunization  
Pre/post 
survey; focus 
groups 
Greater 
Vancouver, 
British 
Columbia 
34 pregnant 
and 
postpartum 
women 
recruited from 
obstetric 
waiting rooms 
Patient level:  
+     perception of 
disease severity 
+     perception of 
disease 
susceptibility for 
self and infant 
+     perceived 
benefit of 
vaccination 
-      omission bias 
-      ‘natural’ 
ideology 
+      decisiveness 
about vaccination 
+      health care 
provider 
recommendation 
Possible 
selection bias 
(rate of refusal 
58%); large 
proportion of 
patients were 
of high 
socioeconomic 
means and 
highly 
educated 
compared to 
the general 
Canadian 
population. 
Brien 2012 2009 Pandemic 
influenza 
immunization 
Cross-sectional 
study using 
population data 
Montreal, 
Quebec 
Denominator 
of 19,490 
pregnant 
women 
Patient level: 
-       social 
deprivation 
 
Limited 
information 
specific to 
coverage 
among 
pregnant 
women 
Desjardins 2017 2015 Seasonal 
influenza 
immunization 
Survey of 
prenatal care 
providers 
Quebec 344 prenatal 
care providers 
Provider level:
  
+      provider age 
>40 years 
Possible 
selection bias 
(37% response 
rate). Possible 
information 
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+      higher 
prenatal clinical 
volume 
+      academic 
practice 
+/-    differences 
between 
professions 
 
bias (self-
reported data. 
Fabry 2011 2010 Pandemic 
influenza 
immunization 
Cross-sectional 
survey 
Sherbrooke, 
Quebec 
250 pregnant 
or postpartum 
women 
Patient level:  
+/-   trimester of 
pregnancy 
+      education 
through 
government 
websites 
+      belief in the 
efficiency of 
vaccine 
+      
recommendation 
from health 
professional 
 
Risk of 
selection bias 
is low (refusal 
rate 5.2%).  
Possible 
information 
bias secondary 
to self-
reported 
vaccination 
status. 
Gracie 2011 2011 Pandemic 
influenza 
immunization 
Cross-sectional 
survey 
Calgary, 
Alberta 
509 pregnant 
women 
Patient level: 
+      higher 
household 
income 
+      higher 
education 
+      planned 
pregnancy 
Risk of 
selection bias 
(response rate 
of 79%); large 
proportion of 
patients were 
of high 
socioeconomic 
means and 
highly 
educated 
compared to 
the general 
Canadian 
population. 
Possible 
information 
bias secondary 
to self-
reported 
vaccination 
status. 
Halperin 2014 2005-
2006 
and 
2011 
Seasonal 
influenza 
immunization 
Cross-sectional 
survey at time 
points pre- and 
post-H1N1 
Halifax, 
Nova Scotia 
821 pregnant 
women 
Patient level: 
+      enhanced 
knowledge about 
influenza and 
vaccinations 
post-pandemic 
+     higher 
education 
+     higher 
socioeconomic 
status 
+     
recommendation 
from a physician 
 
Possible 
selection bias: 
large 
proportion of 
patients was of 
high 
socioeconomic 
means and 
highly 
educated 
compared to 
the general 
Canadian 
population.  
Self-reported 
vaccination 
status. 
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Hilderman 2011 2000-
2008 
Seasonal 
influenza 
immunization 
Cross-sectional 
study using 
population data 
Manitoba All deliveries in 
the province 
between 2000-
2008 
(denominator 
not provided) 
Patient level: 
+     family 
physician as 
prenatal care 
provider 
+     comorbid 
conditions 
+     higher 
income 
+     older 
maternal age 
+     child at home 
<24 months 
+     more 
frequent prenatal 
visits 
 Data available 
from 
population 
databases 
provided 
limited 
individual level 
explanations 
for the 
identified 
trends 
Kowal 2015 n/a Immunizations 
during 
pregnancy in 
general 
In-person 
interviews 
Edmonton, 
Alberta 
23 immigrant 
women from 
South Asia and 
China 
Patient level: 
-      language 
barrier for verbal 
and written 
information 
about vaccination 
+     provider 
recommendation 
+     family and 
social networks 
 
Possible 
selection bias 
in terms of 
recruitment 
strategy.  Self-
reported 
vaccination 
behavior not 
corroborated 
with rates of 
uptake. 
Lee 2004 2002 Seasonal 
influenza 
immunization 
Mailed out 
survey 
Ontario 113 midwives 
and midwifery 
students 
Provider level: 
+/-  year of 
graduation 
+     knowledge of 
impact of 
influenza in 
pregnancy 
+/-   beliefs about 
immunization in 
general 
Possible 
selection bias 
(36-42% 
response rate).  
Self-reported 
behavior may 
present 
possible 
information 
bias. 
Legge 2014 2010-
2012 
Seasonal 
influenza 
immunization 
Cross-sectional 
study using 
population data 
Nova Scotia 12,223 
pregnant 
women 
Patient level: 
+      higher 
income 
+/-   marital 
status 
+      higher risk 
pregnancy 
-       rural 
residence 
 
Data available 
from 
population 
databases 
provided 
limited 
individual level 
explanations 
for the 
identified 
trends 
Liu 2012 2009-
2010 
Pandemic 
influenza 
immunization 
Cross-sectional 
study using 
population data 
Ontario 64,293 
pregnant 
women 
Patient level: 
+     family 
physician as 
prenatal care 
provider 
+     higher 
socioeconomic 
status 
+     older 
maternal age 
+     medical 
comorbidities 
+     earlier 
prenatal care 
Data available 
from 
population 
databases 
provided 
limited 
individual level 
explanations 
for the 
identified 
trends 
MacDougall 2016 2008-
2014 
Tdap Surveys 
distributed in 
Multiple 
urban 
346 pregnant 
women 
Patient level: Possible 
selection bias 
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conjunction 
with 
recruitment 
into a clinical 
trial 
centers in 
Canada 
(Edmonton, 
AB; 
Montreal 
QC; 
Vancouver, 
BC; Ottawa, 
ON; Halifax, 
NS) 
+     physician 
recommendation 
-      low 
knowledge about 
pertussis and the 
pertussis vaccine 
+     generally 
favourable 
attitude toward 
vaccination in 
pregnancy 
 
(response rate 
not listed). 
Large 
proportion of 
patients were 
of high 
socioeconomic 
means and 
highly 
educated 
compared to 
the general 
Canadian 
population..  
Sakaguchi 2011 2009 Pandemic 
influenza 
immunization 
Telephone 
survey 
Centre in 
Toronto, ON 
with 
participants 
from all of 
Canada 
130 pregnant 
women 
accessing 
MotherRisk 
services 
Patient level: 
-     media 
provided 
confusing 
information 
+    accessing 
MotherRisk  
-      concern of 
safety to the 
fetus 
Selection 
limited to 
women 
accessing the 
MotherRisk 
services may 
limit 
generalizability 
of conclusions 
Tong 2008 2003-
2004 
Seasonal 
influenza 
immunization 
Cross-sectional 
survey of 
prenatal care 
providers and 
postpartum 
women 
Toronto, 
Ontario 
227 prenatal 
care providers 
and 185 post-
partum 
women 
Provider level: 
-       knowledge 
gaps 
+/-   Provider 
type (FP vs. OB) 
+      attitudes 
toward 
vaccination 
 
Patient level: 
-       knowledge 
gaps 
-       concern 
safety to the 
fetus  
+      
recommendation 
by a physician 
Possible 
selection bias 
(response rate 
34-55%). Self-
reported 
vaccination 
behavior.  
Yudin 2009a 
Pregnant 
Women’s 
Knowledge of 
Influenza and the 
Use and Safety of 
the Influenza 
Vaccine During 
Pregnancy 
2006 Seasonal 
influenza 
immunization 
Cross sectional 
survey of post-
partum women 
Toronto, 
Ontario 
100 
postpartum 
women 
Patient level: 
-      knowledge 
gaps 
-      vaccine 
offered 
infrequently 
-      concern for 
safety to the 
fetus 
 
Possible 
selection bias 
(convenience 
sample).   
Yudin 2009b 
Impact of Patient 
Education on 
Knowledge of 
Influenza and 
Vaccine 
Recommendations 
Among Pregnant 
Women 
2006-
2007 
Seasonal 
influenza 
immunization 
Cross sectional 
survey of post-
partum women 
pre- and post-
implementation 
of educational 
brochure 
Toronto, 
Ontario 
Total of 400 
post-partum 
women (100 
from 2006 and 
300 from 
2007) 
Patient level: 
+      direct 
patient education 
 
Possible 
selection bias 
(convenience 
sample).  
Possible 
information 
bias secondary 
to self-report 
of vaccination 
behavior  
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Yudin 2010 2007 Seasonal 
influenza 
immunization 
Calculation of 
vaccination rate 
after 
implementation 
of clinical nurse 
champion for 
immunization 
in prenatal 
clinic 
Toronto, 
Ontario 
n/a Patient level: 
+      dedicated 
staffing to offer 
prenatal 
vaccination 
 
Aggregate level 
data with 
limited data 
points 
available to 
control for 
confounding 
when 
comparing to 
previous 
vaccination 
rates 
 
 
Overview of available literature 
Two of the 17 included studies had national or multicenter Canadian representation among 
participants while the others had single-province participation from Nova Scotia (2), Quebec (3), 
Ontario (6), Manitoba (1), Alberta (2) and British Columbia (1).  Most of the available literatures 
focused on the seasonal influenza vaccine (10) and the pandemic influenza H1N1 vaccine (6) 
during pregnancy, with one study looking at tetanus-diphtheria-pertussis vaccination during 
pregnancy.  Diverse study methodologies have been employed, including cross-sectional 
observational studies of population-level data (4), survey-based studies of prenatal care providers 
(3), survey-based studies of pregnant or post-partum women (9) , interview and focus group 
methods with pregnant and post-partum women (2), and investigations of interventions designed 
to increase vaccine uptake (1). 
Patient-level barriers and facilitators 
Six studies12-17 reported on characteristics of patients associated with receipt or non-receipt of 
vaccinations during pregnancy.  Seven additional studies evaluated knowledge, attitudes, beliefs 
and intended behavior of pregnant women toward immunization in pregnancy18-24.  Given the 
potential effect that H1N1 media coverage and response campaigns targeting pregnant women 
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may have had on uptake, we have presented studies on patient-level barriers and facilitators 
separately for cohorts prior to 2009-2010 H1N1 pandemic influenza (7) and those during the 
2009-2010 H1N1 pandemic or thereafter (8).  
Patient-level barriers and facilitators prior to 2009-2010 
Prior to the H1N1 pandemic outbreak, the literature considering patient factors, knowledge and 
attitudes about the influenza vaccine during pregnancy identified knowledge gaps, especially 
about vaccine safety and disease severity, as a substantial barrier to vaccination.  Important 
facilitators of vaccination in this period were the desire of pregnant women to protect their 
infants and the recommendation of a health care provider. 
Prior to the 2009-2010 pandemic influenza, the available literature indicates low uptake of the 
influenza vaccine during pregnancy.  A population-based cohort study from Manitoba reported a 
6% rate of uptake for the influenza vaccine during pregnancy by 200815 and found low-income, 
young age, fewer prenatal care visits prior to 32 weeks of gestational age to be associated with 
low uptake of the influenza vaccine during pregnancy15. A Toronto-based survey of post-partum 
women by Tong found in 2003-04 that 14% self-reported having received the influenza vaccine 
during pregnancy22.  Findings from both the population-based cohort study and the survey-based 
study suggested that maternal intention to protect the infant was an important predictor for 
receipt of the influenza vaccination.  Tong et al found that women who knew that maternal 
influenza vaccination was beneficial for their babies were more likely to have received the 
influenza vaccine during pregnancy (OR 3.5, 95% CI 1.4-9)22; and Hilderman et al demonstrated 
that women were more likely to have received the influenza vaccine during pregnancy if they 
had had comorbidities or if they had a child at home under 24 months of age15.  Similarly, the 
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Manitoba Immunization Study found that recently pregnant women were twice as likely than 
pregnant women to receive the influenza vaccine15. 
Knowledge gaps among pregnant individuals prior to 2009-2010 pandemic influenza were 
clearly illustrated through two Toronto-based surveys22,23.  Overall, knowledge was imperfect, 
with respondents answering only 62% of knowledge questions correctly23.  Misperception about 
the safety of the influenza vaccine during pregnancy was common, with 54% of women 
believing that the influenza vaccine should be avoided during pregnancy22 and over 20% 
believing it was associated with birth defects23.  The potential severity of influenza infection 
during pregnancy was underestimated with the majority of women believing that influenza 
infection for a pregnant woman carried the same risk as influenza infection for a non-pregnant 
woman23.  Tong et al demonstrated a positive correlation between knowledge and receipt for the 
influenza vaccine22.  Relevant to misconceptions of vaccine safety, survey by Yudin et al found 
that 80% of women survey preferred to be vaccinated against influenza in the post-partum 
period23.   
The role of the health-care provider was also important in the pre-H1N1 studies.  Women 
receiving prenatal care from an obstetrician exclusively were less likely to be vaccinated in the 
Manitoba cohort compared to women receiving care from a primary care physician. Tong et al 
found that women who received a recommendation from their physician were significantly more 
likely to have received the influenza vaccine during pregnancy (OR 34.5, 95%CI 10.5-119)22.   
Patient-level barriers and facilitators subsequent to 2009-2010 
Subsequent to the H1N1 pandemic outbreak, uptake of influenza vaccination in pregnancy 
increased somewhat, and the literature considering patient factors, knowledge and attitudes about 
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the influenza vaccine during pregnancy identified that knowledge about disease severity and 
vaccine safety appeared to have improved compared to prior to studies conducted H1N1.  
Physician recommendation and clarity of information became increasingly cited as facilitators to 
vaccination for pregnancy women.  
The Canadian literature reporting on cohorts during or following the 2009-2010 H1N1 pandemic 
influenza report higher rates of uptake of the influenza vaccine among pregnant women 
compared to the period prior to 2009-2010.  This is particularly striking for the H1N1 pandemic 
influenza vaccine with self-reported rates of uptake of up 67-76%13,14,24 in Quebec, Alberta and 
Nova Scotia and population-based estimates of 38% in Ontario17.  Estimates of influenza vaccine 
uptake during pregnancy based on self-report differ from those based on population-level data.  
Post-H1N1, older maternal age, higher income, increased education and presence of medical 
comorbidities continued to be associated with higher uptake of the influenza vaccine during 
pregnancy14,16,17.   
Type of provider continued to be associated with uptake of the influenza vaccine during 
pregnancy with women in Ontario being more likely to receive the pandemic H1N1 influenza 
vaccine if their prenatal care was provided by a family physician17.  Survey-based studies from 
the post-H1N1 time period continue to underscore the importance of physician recommendation 
as a key motivator for receipt of the influenza vaccine during pregnancy13,20,24 and one survey-
based study comparing cohorts pre- and post-H1N1 suggests that this was becoming an 
increasingly important motivator24.   
Patient concerns about safety remained the most commonly cited barrier to influenza vaccination 
during pregnancy among these studies13,20, though Halperin et al found the proportion of women 
17 
 
reporting that it was best to avoid all vaccinations during pregnancy declined in the period 
following H1N124.  Notably, appreciation for disease severity appeared increased in this time 
period, with 73.1% of women in one survey-based study citing “concern about the risk of H1N1 
infection in the fetus and/or themselves” to be the primary motivator for receiving the H1N1 
pandemic influenza vaccine during pregnancy20.   
Bettinger et al conducted focus groups and pre/post flu season surveys involving 22 women 
sampled from British Columbia to understand their rationale for receipt or non-receipt of both 
the seasonal influenza and the H1N1 pandemic vaccination during pregnancy18.  While most of 
the sample of women self-identified as being pro-vaccine and agreed that vaccines are effective 
and safe for pregnant women, just half the sample agreed that they had enough information to 
make a decision about being vaccinated during pregnancy.  Only a minority of women reported 
having had a health care provider discuss vaccination with them during pregnancy and 
ambiguous information combined with aversion to ambiguity were cited as important barriers to 
receipt of a vaccination during pregnancy18.  
A qualitative study by Kowel et al conducted semi-structured interviews with 23 women in 
Edmonton, Alberta, who had recently immigrated to Canada from South or East Asia19.  
Important themes that emerged from this study were that the sample of women demonstrated 
significant trust in the recommendations of health-care providers and in Canadian 
recommendations about vaccination during pregnant.   The majority of women did not seek 
information beyond the health care provider; however, few recalled having had vaccinations 
discussed by a health care provider during their pregnancy.  A particularly poignant quote was 
even used as the title for the study, “If they tell me to get it. I’ll get it.  If they don’t…”   
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Participants in this study identified language of spoken and written information to be an 
important barrier to accessing vaccine information in Canada19. 
Chronologic assessment of Canadian information related to barriers to vaccination during 
pregnancy at the level of the patient revealed that while knowledge about safety and disease 
severity has evolved following 2009-2010 H1N1 pandemic influenza, several important barriers 
persist: the need for clear and unambiguous information about safety and the necessity of a 
recommendation from a prenatal care provider.  
Care Provider-level barriers and facilitators 
Prenatal care provider characteristics and practices that have consistently been identified as 
potential barriers or facilitators to vaccination in pregnancy include provider specialty (with 
patients of family doctors more likely to be vaccinated against influenza than those who received 
prenatal care from an obstetrician only), provider vaccine knowledge (with higher knowledge 
associated with higher likelihood of offering vaccination), and practice setting (with physicians 
working in academic centres or family practices that offered other vaccinations more likely to 
recommend or offer vaccination in pregnancy). 
Five studies15,22,25,26 reported on characteristics of prenatal care providers (e.g. specialty, vaccine 
knowledge, practices etc.).  Three of these22,25,26  used survey-based designs with response rates 
of 32-43%, and inquired about prenatal care provider self-reported knowledge, beliefs and 
practice patterns in Ontario22,25 and Quebec26.  Provider self-reports of recommendation to be 
vaccinated against influenza are stable between two surveys of prenatal care providers, one prior 
and the other subsequent to 2009-2010 pandemic H1N1, with 63.4%22 and 60%26 of providers 
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reporting recommending the influenza vaccine for pregnant women, respectively.  However, the 
most recent survey of providers in Quebec26 reports higher self-reported rates of recommending 
the influenza vaccine to pregnant women for obstetricians (80% vs. 65%) and midwives (12% 
vs. 8.5%) compared to previous reports22,25.   
Vaccine knowledge by care providers was consistently associated with higher likelihood of 
recommending the influenza vaccine during pregnancy22,25,26.  An important knowledge gap 
identified by two pre-H1N1 studies relates to failure to recognize that influenza could have 
severe consequences for pregnant women, with 40% of obstetricians and family practitioners22 
and 63% of midwives25 having answered questions on this topic incorrectly.  Knowledge about 
safety and efficacy were high among obstetricians and family practitioners, but low among 
midwives prior to pandemic H1N122,25.  Other facilitating factors associated with higher 
likelihood of offering the influenza vaccine during pregnancy were a positive attitude toward the 
influenza vaccine22,25 and having personally received the influenza vaccine22,25   
Two studies reported provider characteristics associated with uptake of the influenza vaccine 
during pregnancy using population-based data15,17.  Here, information about provider 
characteristics gleaned from population-based data is limited to the association between specialty 
of primary prenatal care provider and uptake rate of the influenza vaccine during pregnancy.  
Both of these studies demonstrate that women who have a family physician as a prenatal care 
provider are significantly more likely to receive an influenza vaccine compared to who are 
followed by an obstetrician alone or by a midwife during pregnancy15,17. 
In summary, more recent publications suggest that at the level of the Canadian health-care 
provider, there is improved knowledge about vaccinations during pregnancy as well as increased 
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adherence to guidelines for all types of prenatal care providers.  However, the self-reported rates 
of guideline adherence do not align with the population based estimates of actual vaccine 
delivery.  As such, further research is needed to identify the structural barriers that limit a 
provider’s ability to recommend and deliver vaccines to pregnant women despite knowledge and 
desire to do so.   
System-level Barriers and Facilitators 
Very few available studies reported specifically on structural barriers that affect the provider’s 
ability to administer vaccines to pregnant women.  However, Desjardins did identify a higher 
rate of adherence to guidelines about vaccination in pregnancy for physicians working in an 
academic centre (66% vs. 53%, p=0.03).  Additionally, Tong et al, who found that family 
physicians were more likely to recommend the influenza vaccine during pregnancy, identified 
that all family physicians surveyed worked in practices that offered at least one type of vaccine, 
compared to only 26% of obstetricians included in their sample.  
We identified two Canadian studies that focused on interventions aiming to increase knowledge 
and uptake of influenza vaccination during pregnancy27,28.   In the first, distribution of an 
information pamphlet about the influenza vaccine during the prenatal period resulted in increased 
knowledge scores and improved vaccination rates from 19% to 56% for a cohort of post-partum 
women in Toronto, ON28.  The second study, also from Toronto, describes the implementation of 
a “nurse champion” in the prenatal clinic setting.  This intervention is characterized both by 
capacity for point-of-care vaccination and by enhanced clinical staffing (the “nurse champion”) 
to deliver this service. This nurse was employed for a brief two-week period and had no other 
responsibilities other than to approach patients, educate, offer and administer the influenza 
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vaccine.  This study reported an uptake of 42% for the influenza vaccine among the pregnant 
women in this sample (n=266) compared to a 16-21% uptake rate reported for this clinic in prior 
seasons.  Neither study had a robust control group to quantify the magnitude of effect of the 
interventions.  Limitations notwithstanding, both studies from Toronto, ON were conducted prior 
to 2009-2010 pandemic H1N1 influenza and the reported rates of influenza vaccine uptake 
among these pregnant cohorts were considerably higher than contemporary rates of uptake 
discussed above. These findings suggest that small changes in care delivery structure that aim to 
inform and personally invite pregnant individuals to be vaccinated may be effective strategies.   
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DISCUSSION 
Although influenza vaccination is recommended for all pregnant individuals in Canada, rates of 
seasonal influenza vaccine in pregnancy remain very low, especially when considered in 
comparison to other similarly resourced countries. Vaccination during pregnancy is becoming a 
mainstay for improving rates of maternal and neonatal morbidity and the number of vaccinations 
that are indicated for use in pregnancy is likely to increase in the future. 
Our review of the Canadian literature has identified barriers and facilitators to vaccination in 
pregnant individuals at the level of the patient and the provider. These barriers and facilitators 
are summarized in the Table 2. We also found indications that targeted outreach to pregnant 
individuals may be effective in increasing vaccine knowledge and uptake.  Among patients and 
providers alike, improved knowledge and positive beliefs about immunization were found to be 
important facilitators for immunization in pregnancy.  Pregnant patients appear to be especially 
motivated to be vaccinated when a recommendation is made by a prenatal care provider.  
Women receiving prenatal care from family physicians were more likely to be immunized 
compared to women receiving prenatal care exclusively through an obstetrician.  It is likely that 
system barriers (e.g, logistical ease of managing vaccine stock) influence the ability of a prenatal 
care provider to deliver vaccines to prenatal patients, but to date, there are virtually no published 
studies to elucidate the system barriers relevant to practitioners in Canada.   
The Canadian health care system is dramatically different from that of our neighbours to the 
south; therefore, when considering health services issues we cannot rely solely on evidence from 
a largely privatized and highly fragmented system of delivering health care.  However, the bulk 
of the existing research on the question of barriers and facilitators to vaccination in pregnancy 
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has been conducted in US settings. To address this knowledge gap, further research is required to 
better understand patient, provider and system level barriers to maternal vaccination in Canada.  
In particular, in-depth, context-sensitive methods such as ethnography, which can delve into 
cultural and structural factors affecting vaccine uptake in Canadian settings, would be of great 
value. Moreover, efforts to understand barriers and improve the uptake of vaccination during 
pregnancy would benefit from strengthening of immunization registries in a variety of 
jurisdictions arounds the country to provide comprehensive and objective estimates of vaccine 
coverage.   
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CONCLUSION 
Even the safest and most effective vaccine is of limited use if it is not accepted by patients, 
recommended by care providers and effectively delivered within the health care system. 
Indications for vaccination in pregnancy are likely to expand in the coming decades; therefore, 
there is an urgent need to identify determinants of vaccine acceptance and strategies to improve 
the uptake of vaccinations during pregnancy that will perform well in Canadian contexts.  
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Appendix A: MEDLINE search strategy 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to 
Present 
Date: 11 July, 2017 
Search: 
1. Exp Vaccines/   209070 
2. Exp Vaccination/  75265 
3. Exp Immunization/  160635 
4. Exp Pregnancy/   839743 
5. Exp Canada/   144442 
6. 1 or 2 or 3   295774 
7. 3 and 4 and 5   112 
8. Limit 6 to (humans and yr="2001 -Current" and (english or french)) 57 
